Drug Trial Radar · NCT05643534
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
180
Actual
Start
Nov 15, 2022
Primary completion
Aug 20, 2026
Study completion Aug 20, 2026
Sponsor
- Lead sponsor
- ArdelyxIndustry
- Sponsor type
- Industry
- First posted
- Dec 8, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of tenapanor (25 mg and 50 mg) in pediatric patients (≥12 and \<18 years old) with IBS-C when administered twice daily (BID) for 12 consecutive weeks.
Conditions
- Irritable Bowel Syndrome With Constipation (IBS-C)
Interventions
Tenapanor 50 MGDrug
Participants will receive tenapanor 50 mg BID (total of 100 mg daily)
Tenapanor 25 mg bidDrug
Participants will receive tenapanor 25 mg BID (total of 50 mg daily)
PlaceboDrug
Participants will be randomized to receive matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- 6/12-week APS (abdominal pain and SBM) +2 responseTime frame: 12 weeks
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
G & L Research, LLC
Foley, Alabama
Eclipse Clinical Research
Tucson, Arizona
Applied Research Center of Arkansas
Little Rock, Arkansas
Advanced Research Center, Inc.
Anaheim, California
Connecticut Children's Medical Center
Hartford, Connecticut
Prohealth Research Center
Doral, Florida
I.H.S. Health, LLC
Kissimmee, Florida
Waterway Research & Associates Corp
Miami, Florida
Valencia Medical and Research Center
Miami, Florida
Orlando Health, Inc.- APH Center for Digestive Health and Nutrition
Orlando, Florida
Florida Pharmaceutical Research and Associates, Inc.
South Miami, Florida
Clinical Research Institute
Stockbridge, Georgia
OSF Saint Francis Medical Center
Peoria, Illinois
Riley Children's Health IUH
Indianapolis, Indiana
Maine Health
Portland, Maine
Boston Children's Hospital
Boston, Massachusetts
Mankato Clinic/ Javara Research Ltd
Mankato, Minnesota
Boys Town National Research Hospital
Boys Town, Nebraska
Med Clinical Research Partners, LLC
Irvington, New Jersey
University of New Mexico Health Sciences Center
Albuquerque, New Mexico
SUNY Downstate Medical Center
Brooklyn, New York
University of Rochester
Rochester, New York
Advantage Clinical Trials
The Bronx, New York
Atrium Health
Charlotte, North Carolina
Duke University School of Medicine
Durham, North Carolina
Wilmington Health
Wilmington, North Carolina
Frontier Clinical Research, LLC
Scottdale, Pennsylvania
Frontier Clinical Research, LLC
Smithfield, Pennsylvania
Prisma Health Children's Hospital
Greenville, South Carolina
Advance Clinical Trial PLLC
Abilene, Texas
Maspons Pediatric Gastro
El Paso, Texas
Proactive El Paso, LLC
El Paso, Texas
Texas Digestive Specialists
Harlingen, Texas
AIM Trials, LLC
Plano, Texas
Sun Research Institute
San Antonio, Texas
Pioneer Research Solutions Inc
Sugar Land, Texas
ClinPoint Trials
Waxahachie, Texas
University Physicians and Surgeons, Inc.
Huntington, West Virginia
Frontier Clinical Research
Kingwood, West Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.